Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Synergistic Effects of Aerobic Exercise and Cognitive Training on Cognition in Stroke Patients With Cognitive Decline

19. desember 2016 oppdatert av: Chang Gung Memorial Hospital

Synergistic Effects of Aerobic Exercise and Cognitive Training on Cognition, Physiological Markers, Daily Function and Quality of Life in Stroke Patients With Cognitive Decline

The purpose of this study is to determine the treatment effects of sequential combination of aerobic exercise and cognitive training on cognitive function, physiological markers, daily function, physical function, social participation and quality of life in stroke patients with cognitive decline. The investigators hypothesized that: (1) sequential training protocol can improve outcome measures compared to single mode of training; (2) these treatment effects will retain at 6-month follow-up.

Studieoversikt

Status

Ukjent

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Forventet)

75

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

  • Taiwan
      • Chiayi City, Taiwan, 613
        • Rekruttering
        • Chiayi Chang Gung Memorial Hospital
        • Ta kontakt med:
      • Kaohsiung City, Taiwan, 83301
        • Rekruttering
        • Kaohsiung Chang Gung Memorial Hospital
        • Ta kontakt med:
      • Keelung City, Taiwan, 204
        • Rekruttering
        • Keeling Chang Gung Memorial Hospital
        • Ta kontakt med:
      • Taipei City, Taiwan, 105
        • Rekruttering
        • Taipei Chang Gung Memorial Hospital
        • Ta kontakt med:
      • Taoyuan City, Taiwan, 333
        • Rekruttering
        • Taoyuan Chang Gung Memorial Hospital
        • Ta kontakt med:
    • Taoyuan
      • Kwei-Shan, Taoyuan, Taiwan, 333
        • Rekruttering
        • Chang Gung Memorial Hospital

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

20 år til 90 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  1. Ischemic or hemorrhagic stroke occurring at least 6 months prior to enrollment
  2. Age range from 20 to 90 years
  3. MMSE score ≥ 19
  4. MoCA<26
  5. Self- or informant-reported memory or cognitive complaints or CDR scale ≤ 0.5
  6. Able to follow the study instruction
  7. Adequate cardiopulmonary function to perform aerobic exercise
  8. Able to walk with or without assistive devices

Exclusion Criteria:

  1. Unstable medical history (e.g., recent myocardial infarction) that might limit participation
  2. Concomitant with other neurological disorders (e.g., Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis)
  3. Current participation in another interventional trial

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Aktiv komparator: Cognitive training group
One 60-min session of cognitive training. Before and after the treatment, a total of 2 evaluations were conducted, including clinical assessments and blood test (each 18c.c.). A saliva sample (2 mL) will only be collected once from each subject. A follow-up assessment of clinical outcomes will be conducted at six month after the end of the course of treatment.
Atferdsmessig: Kognitiv trening
Aktiv komparator: Aerobic exercise training group
One 60-min session of aerobic exercise training. Before and after the treatment, a total of 2 evaluations were conducted, including clinical assessments and blood test (each 18c.c.). A saliva sample (2 mL) will only be collected once from each subject. A follow-up assessment of clinical outcomes will be conducted at six month after the end of the course of treatment.
Atferdsmessig: Aerobic exercise training
Eksperimentell: Sequential training group

One 30-min session of aerobic exercise training + one 30-min session of cognitive training.

Before and after the treatment, a total of 2 evaluations were conducted, including clinical assessments and blood test (each 18c.c.). A saliva sample (2 mL) will only be collected once from each subject. A follow-up assessment of clinical outcomes will be conducted at six month after the end of the course of treatment.
Atferdsmessig: Sequential combination of aerobic exercise and cognitive training

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change scores of Montreal Cognitive Assessment (MoCA)
Tidsramme: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Wechsler Memory Scale - Third Edition (WMS-III)
Tidsramme: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Wechsler Adult Intelligence Scale - Third Edition (WAIS-III)
Tidsramme: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Useful Field of View (UFOV)
Tidsramme: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Stroop Color-Word test
Tidsramme: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Dual-task test
Tidsramme: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
The dual-task tests will be assessed to determine the ability for an individual to perform 2 tasks simultaneously. The investigators will assess the dual-task performance during walking and performing box and block test. The results of the dual-task tests will provide information regarding to whether the 2 tasks compete for the same class of neural resources or one of the tasks can be carried out automatically.
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Endre score for antioksidativ markør
Tidsramme: Baseline, posttest (forventet gjennomsnitt på 3 måneder)
Antioksidative markører vil bli brukt for å reflektere endringene på oksidativt stress. Spesielt vil vi analysere den totale antioksidantkapasiteten (TAC).
Baseline, posttest (forventet gjennomsnitt på 3 måneder)
Endre score for plasmalipidnivå
Tidsramme: Baseline, posttest (forventet gjennomsnitt på 3 måneder)
Kolesterolforholdet (totalt kolesterol delt på lipid med høy tetthet) vil bli evaluert for å reflektere lipidnivået i blodet.
Baseline, posttest (forventet gjennomsnitt på 3 måneder)
Change scores of serum BDNF level
Tidsramme: Baseline, posttest (an expected average of 3 months)
Baseline, posttest (an expected average of 3 months)
Change scores of Glucose indicator
Tidsramme: Baseline, posttest (an expected average of 3 months)
HbA1C level will be tested to investigate the relationships between blood glucose level and aerobic exercise.
Baseline, posttest (an expected average of 3 months)
Change scores of Functional Independence Measure (FIM)
Tidsramme: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Lawton Instrumental Activities of Daily Living Scale (Lawton IADL)
Tidsramme: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Stroke Impact Scale (SIS)
Tidsramme: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Caregiver Burden (CB) scale
Tidsramme: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of EuroQol (EQ)-5D questionnaire
Tidsramme: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Timed up and go test (TUG)
Tidsramme: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Six-minute walk test (6MWT)
Tidsramme: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Mobility level
Tidsramme: Baseline, posttest (an expected average of 3 months)
Baseline, posttest (an expected average of 3 months)
Change scores of International Physical Activity Questionnaires (IPAQ)
Tidsramme: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Fugl-Meyer Assessment (FMA)
Tidsramme: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Rivermead Mobility Index (RMI)
Tidsramme: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of muscle strength
Tidsramme: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
We will evaluate isometric knee flexors and extensors muscle strength using handheld dynamometer. Also, we will use hand dynamometer to measure grip strength of the affected and less affected hand while the participant is seated, with the elbow at 90-degree flexion. We will record the mean value of 3 attempts.
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Community Integration Questionnaire (CIQ)
Tidsramme: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Geriatric Depression Scale (GDS)
Tidsramme: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Genotyping of the BDNF val66met polymorphism
Tidsramme: Between baseline and posttest (an expected average of 3 months)
Between baseline and posttest (an expected average of 3 months)

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Chang Gung Memorial Hospital

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. september 2015

Primær fullføring (Forventet)

1. august 2018

Datoer for studieregistrering

Først innsendt

6. september 2015

Først innsendt som oppfylte QC-kriteriene

14. september 2015

Først lagt ut (Anslag)

16. september 2015

Oppdateringer av studieposter

Sist oppdatering lagt ut (Anslag)

20. desember 2016

Siste oppdatering sendt inn som oppfylte QC-kriteriene

19. desember 2016

Sist bekreftet

1. desember 2016

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • 104-4892A3

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere